Gene · 23607
Papers1,907
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,907
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Insight into the Molecular Mechanism of Diabetic Kidney Disease and the Role of Metformin in Its Pathogenesis. | Int J Mol Sci | 2023 | 37685845 | PubTator, text mining | PubMed |
| Metal Nanoparticles in Alzheimer's Disease. | J Alzheimers Dis Rep | 2023 | 37662608 | PubTator, text mining | PubMed |
| A plasma protein signature associated with cognitive function in men without severe cognitive impairment. | Alzheimers Res Ther | 2023 | 37658429 | PubTator, text mining | PubMed |
| Sex differences in brain protein expression and disease. | Nat Med | 2023 | 37653343 | PubTator, text mining | PubMed |
| Genetics of Alzheimer's Disease in the African American Population. | J Clin Med | 2023 | 37629231 | PubTator, text mining | PubMed |
| Construction and Validation of a Reliable Disulfidptosis-Related LncRNAs Signature of the Subtype, Prognostic, and Immune Landscape in Colon Cancer. | Int J Mol Sci | 2023 | 37629096 | PubTator, text mining | PubMed |
| A Systematic Compilation of Human SH3 Domains: A Versatile Superfamily in Cellular Signaling. | Cells | 2023 | 37626864 | PubTator, text mining | PubMed |
| Cell-type-specific regulation of APOE and CLU levels in human neurons by the Alzheimer's disease risk gene SORL1. | Cell Rep | 2023 | 37611586 | PubTator, text mining | PubMed |
| A novel disulfidptosis and glycolysis related risk score signature for prediction of prognosis and ICI therapeutic responsiveness in colorectal cancer. | Sci Rep | 2023 | 37587262 | PubTator, text mining | PubMed |
| The ever wider clinical spectrum of RMND1-related disorders and limitedness of phenotype-based classifications. | J Mol Med (Berl) | 2023 | 37584739 | PubTator, text mining | PubMed |
| Intervention of next-generation sequencing in diagnosis of Alzheimer's disease: challenges and future prospects. | Dement Neuropsychol | 2023 | 37577182 | PubTator, text mining | PubMed |
| Skin Involvement by Hematological Neoplasms with Blastic Morphology: Lymphoblastic Lymphoma, Blastoid Variant of Mantle Cell Lymphoma and Differential Diagnoses. | Cancers (Basel) | 2023 | 37568745 | PubTator, text mining | PubMed |
| Excitatory Neurons Derived from Human-Induced Pluripotent Stem Cells Show Transcriptomic Differences in Alzheimer's Patients from Controls. | Cells | 2023 | 37566069 | PubTator, text mining | PubMed |
| A phase I study of autologous mesenchymal stromal cells for severe steroid-dependent nephrotic syndrome. | JCI Insight | 2023 | 37561590 | PubTator, text mining | PubMed |
| The expression and prognostic value of disulfidptosis progress in lung adenocarcinoma. | Aging (Albany NY) | 2023 | 37552140 | PubTator, text mining | PubMed |
| Gut-brain connections in neurodegenerative disease: immunotherapeutic targeting of Bin1 in inflammatory bowel disease and Alzheimer's disease. | Front Pharmacol | 2023 | 37521457 | PubTator, text mining | PubMed |
| Recent Advances in Proteinuric Kidney Disease/Nephrotic Syndrome: Lessons from Knockout/Transgenic Mouse Models. | Biomedicines | 2023 | 37509442 | PubTator, text mining | PubMed |
| Non-canonical function of folate/folate receptor 1 during neural tube formation. | bioRxiv | 2023 | 37503108 | PubTator, text mining | PubMed |
| Confirmed Synergy Between the ɛ4 Allele of Apolipoprotein E and the Variant K of Butyrylcholinesterase as a Risk Factor for Alzheimer's Disease: A Systematic Review and Meta-Analysis. | J Alzheimers Dis Rep | 2023 | 37483326 | PubTator, text mining | PubMed |
| Effect of Pathway-Specific Polygenic Risk Scores for Alzheimer's Disease (AD) on Rate of Change in Cognitive Function and AD-Related Biomarkers Among Asymptomatic Individuals. | J Alzheimers Dis | 2023 | 37482996 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23607/papers?page=8